Brian Cheung

Dr. Brian Cheung

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
BCBrian Cheung
Brian Cheung
GSGeeta Sikand
Geeta Sikand
EDElizabeth H. Dineen
Elizabeth H. Dineen
SMShaista Malik
Shaista Malik
AEAilin Barseghian El-Farra
Ailin Barseghian El-Farra
Dyslipidemia is a treatable risk factor for atherosclerotic cardiovascular disease that can be addressed through lifestyle changes and/or lipid-lowering therapies. Adherence to statins can be a clinical challenge in some patients due to statin-associated muscle symptoms and other side effects. There is a growing interest in integrative cardiology and nutraceuticals in the management of dyslipidemia, as some patients desire or are actively seeking a more natural approach. These agents have been used in patients with and without established atherosclerotic cardiovascular disease. We provide an updated review of the evidence on many new and emerging nutraceuticals. We describe the mechanism of action, lipid-lowering effects, and side effects of many nutraceuticals, including red yeast rice, bergamot and others.

19 November 2022 in American Journal of Preventive Cardiology
Verified
Journal Article
Open access
BCBrian Cheung
Brian Cheung